Tiny nanoparticles play a gargantuan role in modern life, even if most consumers are unaware of their presence. They provide essential ingredients in sunscreen lotions, prevent athlete’s foot fungus in socks, and fight microbes on bandages. They enhance the colors…
Tag: Cancer
New proteomics technique gives insights into ubiquitin signalling
Australian researchers are among the first in the world to have access to a new approach to understand intricate changes that control how proteins function in our cells in health and disease. The new proteomics technique called ‘ubiquitin clipping’ allows…
Case Comprehensive Cancer Center Director Elected Senior Member of the National Academy of Inventors
The National Academy of Inventors (NAI) has named 54 academic inventors to the Spring 2019 class of NAI Senior Members, including Stanton L. Gerson, MD, Director of the Case Comprehensive Cancer Center (Case CCC).
Boehringer Ingelheim and MD Anderson form unique virtual research and development center to rapidly advance new cancer therapies
Boehringer Ingelheim and MD Anderson have announced a new multi-year partnership to conduct collaborative research, combining the drug-development capabilities of MD Anderson with the pipeline of novel medicines from Boehringer Ingelheim.
Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma Outcomes
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
How Cigarette Smoke Makes Head and Neck Cancer More Aggressive
A change in the tumor metabolism due to tobacco exposure could open new treatment avenues in head and neck cancer.
Blavatnik Awards for Young Scientists Announces 2019 National Laureates
An ecologist from Stony Brook University, a theoretical physicist from University of Colorado Boulder and a chemical biologist from Harvard University Three female scientists have been named Laureates of the Blavatnik National Awards for Young Scientists, each receiving $250,000, the…
From Simple Tools to High-Level Buy-In, How Doctors Can Help Cancer Patients Quit Tobacco
Penn study shows Moonshot-funded program is making an impact PHILADELPHIA – A simple set of decision-support tools combined with institutional buy-in can help increase the number of cancer patients who engage in treatment to help them quit tobacco, data from…
Abstract Winners Selected for Clinical Research Innovation Meeting
Three abstracts focused on improving clinical trials processes have been selected for formal presentation at the Association of American Cancer Institutes’ (AACI) Clinical Research Innovation (CRI) annual meeting, July 9-11, in Chicago. The CRI Steering Committee and CRI Education Committee…
By Cannibalizing Nearby Stromal Stem Cells, Some Breast Cancer Cells Gain Invasion Advantage
Cancer biologists and engineers collaborated on a device that could help predict the likelihood of breast cancer metastasis Researchers at the University of Michigan Rogel Cancer Center and U-M College of Engineering have found that breast cancer cells that swallow…
Finding Missing Network Links Could Help Develop New Drugs, Stop Disease, Ease Traffic
Sex, drugs and traffic: Search for missing links in networks could help uncover new cancer treatments, build more efficient traffic networks and stop the spread of sexually transmitted diseases. WASHINGTON, D.C., June 25, 2019 — A new mathematical model of…
Engineered Cell Evolution May Provide Pathway to Halting Cancer Drug Resistance
STONY BROOK, NY, June 24,, 2019 — A significant problem when treating cancer patients remains drug resistance, which often causes chemotherapy treatments to ultimately fail. Scientists in recent years have hypothesized that cell-cell differences, also known as cell heterogeneity, aides…
SOFIE And University Clinic Heidelberg Sign License Agreement For Theranostics That Target Cancer Associated Fibroblasts
LOS ANGELES and HEIDELBERG, Germany, June 21, 2019 /PRNewswire/ — SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class of molecular targeted diagnostics and radiotherapeutics (“theranostics”) that are…
Cancer Research Institute Names New Stars of Cancer Immunotherapy Research
Five U.S. scientists have been awarded $1.25 million each to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment • STARs will explore ways to improve outcomes for cancer patients treated with immunotherapy by uncovering and…
NCCN and AstraZeneca Seek Opportunities to Improve Outcomes in Advanced Ovarian Cancer
NCCN Oncology Research Program (ORP) issues request for proposals to improve quality of care for people with stage III, stage IV, and recurrent epithelial ovarian cancer. PLYMOUTH MEETING, PA [June 20, 2019] — The National Comprehensive Cancer Network® (NCCN®) Oncology…
Leading Health and Technology Organizations Release Common Cancer Data Standards to Enable Sharing Across EHR Systems and Improve Patient Care
Chicago – In an effort to advance cancer data sharing and improve the quality and coordination of patient care, three of the nation’s leading health organizations have established a core set of data elements and recommended technical specifications (the Minimal…